{
  "drug_name": "Clindamycin",
  "drug_id": "clindamycin",
  "generic_name": "clindamycin",
  "brand_names": [
    "Cleocin",
    "Dalacin"
  ],
  "class": "Lincosamide Antibiotic",
  "version": "3.0.0",
  "last_updated": "2025-10-08",
  "routes": [
    "PO",
    "IV"
  ],
  "default_route": "PO",
  "contraindications": {
    "absolute": [
      "clindamycin_allergy",
      "lincomycin_allergy"
    ],
    "relative": [
      "history_of_c_difficile_colitis",
      "inflammatory_bowel_disease"
    ],
    "note": "HIGH RISK OF C. DIFFICILE COLITIS. Use with caution in elderly and those with GI disease."
  },
  "allergy_considerations": {
    "pcn_allergy": {
      "safe": true,
      "contraindicated": false,
      "note": "Excellent alternative for PCN allergy (no cross-reactivity). Covers oral anaerobes and MSSA."
    },
    "severe_pcn_allergy": {
      "safe": true,
      "contraindicated": false,
      "note": "Safe with severe PCN allergy. First-line alternative for dental/oral infections."
    },
    "cephalosporin_allergy": {
      "safe": true,
      "note": "Safe alternative for cephalosporin allergy"
    }
  },
  "pregnancy_category": "B",
  "pregnancy_safe": true,
  "pregnancy_notes": "Safe in all trimesters. Commonly used for dental/SSTI in pregnancy with PCN allergy.",
  "renal_adjustment": {
    "required": false,
    "note": "NO renal dose adjustment needed. Primarily hepatic metabolism."
  },
  "dosing": {
    "by_indication": {
      "dental": {
        "dose": "300 mg PO",
        "frequency": "QID (q6h) or 450 mg TID (q8h)",
        "duration": "7 days",
        "note": "First-line for dental abscess with PCN allergy. Excellent oral anaerobe coverage.",
        "route": "PO",
        "loading_dose": null
      },
      "head_neck": {
        "dose": "300-450 mg PO",
        "frequency": "TID-QID (q6-8h)",
        "duration": "7-10 days",
        "note": "For peritonsillar abscess, Ludwig angina with PCN allergy",
        "route": "PO"
      },
      "ssti_mrsa": {
        "dose": "300-450 mg PO",
        "frequency": "TID-QID (q6-8h)",
        "duration": "7-10 days",
        "note": "Good for MRSA SSTI (not as good as TMP/SMX or doxycycline for CA-MRSA)",
        "route": "PO"
      },
      "aspiration_pneumonia": {
        "dose": "600-900 mg IV",
        "frequency": "q8h",
        "duration": "7-14 days",
        "note": "Excellent anaerobe coverage for aspiration pneumonia",
        "route": "IV"
      },
      "toxic_shock_syndrome": {
        "dose": "900 mg IV",
        "frequency": "q8h",
        "duration": "10-14 days",
        "note": "Added to vancomycin for toxin suppression (inhibits protein synthesis)",
        "route": "IV"
      },
      "necrotizing_fasciitis": {
        "dose": "900 mg IV",
        "frequency": "q8h",
        "duration": "Until debridement complete",
        "note": "Added for toxin suppression (Group A Strep, Clostridium)",
        "route": "IV"
      },
      "bite_wound": {
        "dose": "300-450 mg PO",
        "frequency": "TID-QID",
        "duration": "3-5 days",
        "note": "Alternative for bite wounds with PCN allergy (combine with ciprofloxacin for Pasteurella)",
        "route": "PO"
      },
      "brain_abscess": {
        "dose": "600-900 mg IV",
        "frequency": "q8h",
        "duration": "6-8 weeks",
        "note": "Excellent CNS penetration and anaerobe coverage",
        "route": "IV"
      },
      "pelvic_inflammatory_disease": {
        "dose": "900 mg IV",
        "frequency": "q8h",
        "duration": "Until 24h afebrile, then switch to PO",
        "note": "Combined with gentamicin for polymicrobial coverage",
        "route": "IV"
      },
      "ssti": {
        "dose": "300-450 mg PO",
        "frequency": "TID-QID (q6-8h)",
        "duration": "7-10 days",
        "route": "PO",
        "note": "Good for MRSA SSTI (not as good as TMP/SMX or doxycycline for CA-MRSA)"
      }
    },
    "pediatric": {
      "note": "PO: 10-30 mg/kg/day divided q6-8h. IV: 25-40 mg/kg/day divided q6-8h"
    }
  },
  "monitoring": {
    "required": [
      "clinical response",
      "diarrhea (C. diff risk)"
    ],
    "optional": [
      "liver function tests (if prolonged therapy)"
    ]
  },
  "drug_interactions": {
    "major": [
      "neuromuscular blocking agents (potentiates blockade)"
    ],
    "moderate": [
      "warfarin (may increase INR)",
      "erythromycin (antagonism)"
    ]
  },
  "adverse_effects": {
    "common": [
      "diarrhea (VERY common)",
      "nausea",
      "abdominal pain",
      "rash"
    ],
    "serious": [
      "C. difficile colitis (HIGH RISK - 10-20%)",
      "pseudomembranous colitis",
      "hepatotoxicity",
      "severe hypersensitivity (rare)"
    ],
    "rare": [
      "Stevens-Johnson syndrome",
      "agranulocytosis"
    ]
  },
  "spectrum": {
    "gram_positive": "Excellent (Streptococcus, MSSA, some MRSA - check local susceptibility)",
    "gram_negative": "Poor (no coverage)",
    "anaerobes": "Excellent (Bacteroides, oral anaerobes, Clostridium)",
    "atypicals": "No coverage"
  },
  "notes": [
    "\u26a0\ufe0f HIGH RISK OF C. DIFFICILE COLITIS (10-20%)",
    "First-line alternative for dental infections with PCN allergy",
    "Excellent oral anaerobe coverage",
    "Good for MSSA, variable MRSA coverage (check local susceptibility)",
    "NO gram-negative coverage",
    "Excellent bone/CNS/abscess penetration",
    "NO renal dose adjustment needed",
    "Safe in pregnancy",
    "Added to \u03b2-lactams for toxin suppression (necrotizing fasciitis, toxic shock)",
    "Take with full glass of water to prevent esophagitis",
    "WARN PATIENTS: Report diarrhea immediately (C. diff risk)"
  ],
  "evidence": [
    "IDSA SSTI Guidelines 2014",
    "IDSA Dental Infection Guidelines",
    "Aspiration Pneumonia Guidelines (ATS/IDSA)"
  ]
}